• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.
    All News #Library
    Biotech

    Sarepta Faces New Scrutiny After 3rd Patient Death

    FIERCE BIOTECH

    FDA Rejects Roche`s Earlier DLBCL Bid Over Lackluster US Data

    PRESS RELEASE

    Telomir-1 Reverses Gene Silencing in Prostate Cancer, Beats Chemo

    ACCESSWIRE

    Champions Oncology Announces Appointment of New CEO

    ACCESSWIRE

    FDA Mulls Halting Elevidys Shipments, Sarepta Stock Plunges

    BIOSPACE

    Moderna Scraps Plan for Japan mRNA Manufacturing Facility

    FIERCE PHARMA

    Trogenix Appoints Atif Abbas as CMO, Carolyn as VP

    GLOBENEWSWIRE

    ImCheck’s ICT01 Receives FDA Orphan Drug Designation for Leukemia

    GLOBENEWSWIRE

    Ocugen Doses First Patient in Phase 2/3 Trial for OCU410ST

    GLOBENEWSWIRE

    Generation Bio Announces 1-for-10 Reverse Stock Split

    GLOBENEWSWIRE

    Senti Bio Names Bryan Baum Entrepreneurial Leader and Investor

    GLOBENEWSWIRE

    Connect Biopharma to join BTIG Virtual Biotechnology Conference

    GLOBENEWSWIRE

    Van Herk Investments B.V. Announces Major Stake in Zealand Pharma

    GLOBENEWSWIRE

    Tevogen.AI Gets Global Patent for Immuno AI Technology

    GLOBENEWSWIRE

    Vor Bio Grants Inducement Under Nasdaq Listing Rule 5635(c)(4)

    GLOBENEWSWIRE

    Iovance Biotherapeutics issues Inducement Grants per NASDAQ Rule

    GLOBENEWSWIRE

    New AI APOE4 App Helps Identify Alzheimer’s Risk

    GLOBENEWSWIRE

    Virax Biolabs Gets Nasdaq Notice for Minimum Bid Price Deficiency

    PR NEWSWIRE

    FDA finalizes biosimilars meeting guidance under BsUFA III

    RAPS

    Sarepta Therapeutics Provides Statement on Elevidys

    BUSINESSWIRE

    Keros Therapeutics Doses First Patient in Phase 3 RENEW trial

    GLOBENEWSWIRE

    Nk Gen, Heka Bio Partner on Novel NK Cell Therapy

    GLOBENEWSWIRE

    Harrow, Samsung Bioepis Ink US Ophthalmology Deal

    BUSINESSWIRE

    FDA Approves Pre-filled Version of GSK`s Shingles Vaccine

    PRESS RELEASE

    Sarepta Up 18% After Business Overhaul as Analysts Optimistic

    BIOSPACE

    Danaher India, Thsti Bolster Biomanufacturing in India

    EXPRESS PHARMA

    Abbott Eyes Structural Heart Gains After Boston Scientific Exit

    FIERCE BIOTECH

    BioNTech`s Chief Strategy Officer Heads for The Exit

    FIERCE BIOTECH

    Zymeworks to Report Q2 2025 Financial Results, Host Conference

    GLOBENEWSWIRE

    Immuron FY25 Global Sales Exceed Projection, up 49% on Prior Year

    GLOBENEWSWIRE

    Harvard Bioscience Names New CEO, Adds Two Independent Directors

    GLOBENEWSWIRE

    I-Mab bolsters Givastomig IP portfolio with Bridge Health

    GLOBENEWSWIRE

    Clearside to Explore Options for SCS® Eye Platform

    GLOBENEWSWIRE

    Lisata Therapeutics, WARPNINE Complete iLSTA Trial Enrollment

    GLOBENEWSWIRE

    BioAtla to Present at 2025 ESMO TAT Asia Meeting

    GLOBENEWSWIRE

    BioNTech to Replace Ryan Richardson on Management Board

    GLOBENEWSWIRE

    Tevogen Signs Intent for New In-House Cell Therapy Manufacturing

    GLOBENEWSWIRE

    Creative Medical Tech Gets Nod to Prevent/treat Type 1 Diabetes

    GLOBENEWSWIRE

    OSE Immunotherapeutics Launches Newsletter for Retail Investors

    GLOBENEWSWIRE

    Eledon Pharmaceuticals to Present Tegoprubart Phase 1b Trial

    GLOBENEWSWIRE

    Successful Commercial Launch of Ryoncil

    GLOBENEWSWIRE

    One Biosciences Secures €15 M Series

    PR NEWSWIRE

    Enzymatica AB Sees Strong Growth in Sweden

    PR NEWSWIRE

    10x Genomics, A*STAR launch TISHUMAP Study for AI-Driven Drug

    PR NEWSWIRE

    CureSHANK Urges Families to Start Genetic Testing amid Gene

    PR NEWSWIRE

    Astellas, Korean Gov’t Launch Startup Partnership Program

    PR NEWSWIRE

    Gc Biopharma Gets Approval to Market Barycela in Vietnam

    PR NEWSWIRE

    NLS Pharma Notes Progress in iTOL-102 Type 1 Diabetes Study

    PR NEWSWIRE

    Enhertu + Pertuzumab Get US BTD for HER2+ Breast Cancer

    BUSINESSWIRE

    Novotech Report Explores In-Vivo CAR-T Therapy Economics

    BUSINESSWIRE

    GenSight Publishes Study on Lumevoq Visual Outcomes

    BUSINESSWIRE

    MAIA Bio Publishes Data on Second-Gen Anticancer Drug

    BUSINESSWIRE

    Study Finds Boosters Aid Cancer Patients vs COVID-19

    BUSINESSWIRE

    EMA Identifies Need to Adapt Frameworks For AI integration

    RAPS

    Otsuka inks $613M deal for Swedish Biotech`s IL1RAP Antibodies

    FIERCE BIOTECH

    Sanofi’s SAR446597 Earns Fast Track Designation in the US

    PRESS RELEASE

    Biocon Biologics Gains USFDA approval for Kirsty

    EXPRESS PHARMA

    AstraZeneca for Clearing Protein Fails Main Goal in Late-Stage

    PRESS RELEASE

    Sarepta to Cut 500 Jobs, Add Black-Box Warning on Gene Therapy

    REUTERS

    Sellas’ CDK9 Inhibitor Tied to 50% Response Rate in AML in Ph 2

    FIERCE BIOTECH

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.